Meteora Capital »

Amicus Therapeutics shares owned by Meteora Capital

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Meteora Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $821k 57k 14.46
2025-12-31 $7.2M 508k 14.24

More positions owned by Meteora Capital

M3brigade Acquisition V Corp (MBAV)
Cantor Equity Partners I (CEPO)
Republic Digital Acquisition (RDAG)
Cantor Equity Partners Iii I (CAEP)
Crane Hbr Acquisition Corp I
Krakacquisition Corporation
Gores Hldgs X (GTEN)
Apex Treas Corp (APXT)
Dynamix Corp (ETHM)
Investcorp Europe Acquisitio (IVCBF)
Armada Acquisition Corp Ii (XRPN)
Cal Redwood Acquisition Corp (CRAQ)
Clearw.a.hld. (CWAN)
Trailblazer Acquisition Corp (BLZR)
Procap Acquisition Corp (PCAP)

View all positions for Meteora Capital

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
UBS Group
State Street Corporation
Vanguard Capital Management
Pentwater Capital Management
Vanguard Portfolio Management
Glazer Capital
Goldman Sachs Group
Bellevue Group
HBK Investments
Geode Capital Management
Millennium Management
Morgan Stanley
CNH Partners

View all funds holding Amicus Therapeutics